Latest Posts
About This Stock
More About This Stock
Read
Read
Regulus Therapeutics Receives FDA Clinical Hold For Hepatitis C Drug
Article By:
Terry Chrisomalis
Monday, June 27, 2016 11:35 PM EDT
Shares of Regulus Therapeutics tanked by 60% after the company announced that the FDA has placed a clinical hold on its Hepatitis C drug candidate.
In this article: RGLS
Regulus Receives Final Milestone Payment From Biogen For Multiple Sclerosis Development
Article By:
Terry Chrisomalis
Wednesday, October 28, 2015 1:46 PM EDT
Today Regulus Therapeutics (RGLS) announced that it has received its fourth and final milestone payment from Biogen (BIIB).